[go: up one dir, main page]

KR930703355A - 항생물질 ge2270 인자의 아미드 - Google Patents

항생물질 ge2270 인자의 아미드

Info

Publication number
KR930703355A
KR930703355A KR1019930701997A KR930701997A KR930703355A KR 930703355 A KR930703355 A KR 930703355A KR 1019930701997 A KR1019930701997 A KR 1019930701997A KR 930701997 A KR930701997 A KR 930701997A KR 930703355 A KR930703355 A KR 930703355A
Authority
KR
South Korea
Prior art keywords
antibiotic
amide
factor
amide derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019930701997A
Other languages
English (en)
Other versions
KR100225763B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR930703355A publication Critical patent/KR930703355A/ko
Application granted granted Critical
Publication of KR100225763B1 publication Critical patent/KR100225763B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
KR1019930701997A 1991-01-03 1992-01-02 항생 물질 ge 2270 인자의 아미드 Expired - Lifetime KR100225763B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91100123 1991-01-03
EP91100123.8 1991-01-03
PCT/EP1992/000002 WO1992012172A1 (en) 1991-01-03 1992-01-02 Amides of antibiotic ge 2270 factors

Publications (2)

Publication Number Publication Date
KR930703355A true KR930703355A (ko) 1993-11-29
KR100225763B1 KR100225763B1 (ko) 1999-10-15

Family

ID=8206281

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930701997A Expired - Lifetime KR100225763B1 (ko) 1991-01-03 1992-01-02 항생 물질 ge 2270 인자의 아미드

Country Status (18)

Country Link
US (1) US5599791A (ko)
EP (2) EP0565567B1 (ko)
JP (1) JP3183508B2 (ko)
KR (1) KR100225763B1 (ko)
CN (1) CN1063110A (ko)
AT (1) ATE117320T1 (ko)
AU (1) AU662122B2 (ko)
CA (1) CA2093219C (ko)
DE (1) DE69201236T2 (ko)
ES (1) ES2067325T3 (ko)
FI (1) FI932944A0 (ko)
HU (1) HU224072B1 (ko)
IE (1) IE920005A1 (ko)
IL (1) IL100572A (ko)
MX (1) MX9200015A (ko)
NZ (1) NZ241216A (ko)
WO (1) WO1992012172A1 (ko)
ZA (1) ZA927B (ko)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69108972T2 (de) * 1990-03-08 1995-10-19 Lepetit Spa Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
DE69224497T2 (de) * 1991-08-30 1998-07-02 Biosearch Italia Spa Faktor C2a des Antibiotikums CE 2270
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
DK0675900T3 (da) * 1992-12-22 1998-03-09 Biosearch Italia Spa Antibiotika GE 37468 A, B og C
SI0801655T1 (en) * 1995-02-07 1998-08-31 Biosearch Italia S.P.A. Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
ATE205505T1 (de) * 1995-02-07 2001-09-15 Biosearch Italia Spa Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DK0880541T3 (da) * 1996-02-14 2003-05-05 Biosearch Italia Spa Derivater af antibiotikum GE2270-faktorer
JPH1059997A (ja) * 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
US20050166498A1 (en) * 1999-12-17 2005-08-04 Oakey David D. Carpet tile with cutout section, method and apparatus for production and method of installation
GB0024200D0 (en) * 2000-10-03 2000-11-15 Smithkline Beecham Sa Component vaccine
PT1553967E (pt) 2002-06-17 2011-08-01 Naicons S C A R L Utilização de um derivado amídico do factor a3 do ge 2270 no tratamento da acne
US20070155714A1 (en) 2003-04-30 2007-07-05 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
KR101176450B1 (ko) 2003-12-18 2012-08-30 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 옥사졸리디논-퀴놀론 혼성 항생제
BRPI0506942B1 (pt) * 2004-01-19 2015-07-28 Dsm Ip Assets Bv Síntese bioquímica de ácido 6-amino capróico
PE20121011A1 (es) * 2006-05-31 2012-08-25 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
EP2097423B1 (en) * 2006-12-20 2011-03-02 Novartis AG Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
US8673601B2 (en) 2007-01-22 2014-03-18 Genomatica, Inc. Methods and organisms for growth-coupled production of 3-hydroxypropionic acid
NZ581917A (en) * 2007-06-04 2011-04-29 Novartis Ag Macrocylces and their uses
EP2348008A1 (en) 2007-08-10 2011-07-27 Genomatica, Inc. Methods for the synthesis of acrylic acid and derivatives from fumaric acid
MY156466A (en) 2007-12-12 2016-02-26 Novartis Ag Aminothiazoles and their uses
BRPI0907385A2 (pt) 2008-01-22 2015-07-21 Genomatica Inc Métodos e organismos para utilização de gás de síntese e outras fontes de carbono gasosas e metanol
CA2717586C (en) 2008-03-05 2020-08-11 Genomatica, Inc. Primary alcohol producing organisms
US7799545B2 (en) 2008-03-27 2010-09-21 Genomatica, Inc. Microorganisms for the production of adipic acid and other compounds
EP2285973A4 (en) 2008-05-01 2012-04-25 Genomatica Inc PROCESS FOR PREPARING METHACRYLIC ACID
WO2009155382A1 (en) 2008-06-17 2009-12-23 Genomatica, Inc. Microorganisms and methods for the biosynthesis of fumarate, malate, and acrylate
CN102307986A (zh) 2008-12-16 2012-01-04 基因组股份公司 用于将合成气和其他碳源转化成有用产品的微生物和方法
KR101774400B1 (ko) 2009-04-30 2017-09-04 게노마티카 인코포레이티드 1,3-부탄다이올 생산 유기체
JP2012525156A (ja) 2009-04-30 2012-10-22 ゲノマチカ, インク. イソプロパノール、n−ブタノール、及びイソブタノールの産生のための微生物
DK2427544T3 (da) 2009-05-07 2019-10-07 Genomatica Inc Mikroorganismer og fremgangsmåder til biosyntese af adipat, hexamethylendiamin og 6-aminokapronsyre
BRPI1012877A2 (pt) 2009-05-15 2016-04-05 Genomatica Inc organismo para produção de ciclohexanona
JP2012529889A (ja) 2009-06-10 2012-11-29 ゲノマチカ, インク. Mek及び2−ブタノールの炭素効率のよい生合成のための微生物及び方法
EP2462221B1 (en) 2009-08-05 2017-02-22 Genomatica, Inc. Semi-synthetic terephthalic acid via microorganisms that produce muconic acid
CN107586753A (zh) 2009-09-09 2018-01-16 基因组股份公司 协同产生异丙醇与伯醇,二元醇和酸的微生物和方法
KR20120083908A (ko) 2009-10-13 2012-07-26 게노마티카 인코포레이티드 1,4-부탄다이올, 4-하이드록시부탄알, 4-하이드록시부티릴-coa, 푸트레신 및 관련 화합물의 제조를 위한 미생물 및 관련 방법
EP2491125A4 (en) 2009-10-23 2014-04-23 Genomatica Inc MICRO-ORGANISMS FOR THE MANUFACTURE OF ANILINE
WO2011071682A1 (en) 2009-12-10 2011-06-16 Genomatica, Inc. Methods and organisms for converting synthesis gas or other gaseous carbon sources and methanol to 1,3-butanediol
AU2011209862A1 (en) 2010-01-29 2012-07-26 Genomatica, Inc. Microorganisms and methods for the biosynthesis of p-toluate and terephthalate
US8445244B2 (en) 2010-02-23 2013-05-21 Genomatica, Inc. Methods for increasing product yields
US8048661B2 (en) 2010-02-23 2011-11-01 Genomatica, Inc. Microbial organisms comprising exogenous nucleic acids encoding reductive TCA pathway enzymes
US9023636B2 (en) 2010-04-30 2015-05-05 Genomatica, Inc. Microorganisms and methods for the biosynthesis of propylene
US8580543B2 (en) 2010-05-05 2013-11-12 Genomatica, Inc. Microorganisms and methods for the biosynthesis of butadiene
WO2012018624A2 (en) 2010-07-26 2012-02-09 Genomatica, Inc. Microorganisms and methods for the biosynthesis of aromatics, 2,4-pentadienoate and 1,3-butadiene
EP3628676A1 (en) * 2018-09-28 2020-04-01 Université de Montpellier Modified peptides and their uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406745B1 (en) * 1989-07-04 1995-01-25 GRUPPO LEPETIT S.p.A. Antibiotic GE 2270 factors A1, A2, A3 and H

Also Published As

Publication number Publication date
AU1154492A (en) 1992-08-17
JPH06504768A (ja) 1994-06-02
FI932944L (fi) 1993-06-24
DE69201236D1 (de) 1995-03-02
CA2093219C (en) 2002-04-09
DE69201236T2 (de) 1995-06-01
CN1063110A (zh) 1992-07-29
IL100572A (en) 1997-01-10
HUT64085A (en) 1993-11-29
IE920005A1 (en) 1992-07-15
IL100572A0 (en) 1992-09-06
EP0494078A1 (en) 1992-07-08
WO1992012172A1 (en) 1992-07-23
AU662122B2 (en) 1995-08-24
JP3183508B2 (ja) 2001-07-09
NZ241216A (en) 1994-04-27
MX9200015A (es) 1992-07-31
US5599791A (en) 1997-02-04
FI932944A0 (fi) 1993-06-24
ATE117320T1 (de) 1995-02-15
ES2067325T3 (es) 1995-03-16
ZA927B (en) 1992-09-30
HU224072B1 (hu) 2005-05-30
EP0565567B1 (en) 1995-01-18
HU9301941D0 (en) 1993-09-28
EP0565567A1 (en) 1993-10-20
CA2093219A1 (en) 1992-07-04
KR100225763B1 (ko) 1999-10-15

Similar Documents

Publication Publication Date Title
KR930703355A (ko) 항생물질 ge2270 인자의 아미드
KR100202474B1 (en) Novel tetrapeptide derivative
FI932445A0 (fi) Farmaceutiska foereningar
FI863687A0 (fi) Amider av teikoplaninfoereningar.
SE9100920D0 (sv) New active compounds
HU913462D0 (en) Process for the production of heteroaroyl derivatives of moncyclic betha-lactame antibiotics and of medical preparations containing them
EP0481756A3 (en) Benzamide derivatives
DE3885394D1 (de) Teicoplaninähnliche Derivate.
GR3017749T3 (en) Novel antibiotic compounds and their production.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930702

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19961212

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930702

Comment text: Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 19990211

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19990225

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990529

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19990721

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19990722

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20020621

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20030624

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20040614

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20050630

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20060630

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20070723

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20080630

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20090702

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20100708

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20110615

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20110615

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20121009

Termination category: Expiration of duration